After 13 months of treatment, the patient’s respiratory symptoms improved, KL-6 levels decreased, and chest CT showed improvement, indicating that long-term glucocorticoids or other anti-inflammatory therapies may be beneficial in the treatment of FINCA-induced ILD. Here, MUC1 is linked to interstitial lung disease.